LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 136 filers reported holding LEXICON PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 1.11 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $98,000 | -37.2% | 21,454 | -19.2% | 0.01% | -45.5% |
| Q1 2021 | $156,000 | -53.0% | 26,560 | -84.4% | 0.01% | -57.7% |
| Q1 2020 | $332,000 | -63.0% | 170,500 | +19.6% | 0.03% | -50.9% |
| Q2 2019 | $897,000 | -5.8% | 142,600 | -16.7% | 0.05% | -1.9% |
| Q1 2019 | $952,000 | -7.2% | 171,246 | +10.8% | 0.05% | -5.3% |
| Q4 2018 | $1,026,000 | -54.0% | 154,501 | -26.1% | 0.06% | -38.7% |
| Q3 2018 | $2,230,000 | -22.0% | 208,999 | -12.3% | 0.09% | -14.7% |
| Q2 2018 | $2,860,000 | +40.7% | 238,299 | +0.5% | 0.11% | +58.0% |
| Q1 2018 | $2,033,000 | -13.6% | 237,200 | -0.4% | 0.07% | +1.5% |
| Q4 2017 | $2,352,000 | +1300.0% | 238,097 | +1042.2% | 0.07% | +1600.0% |
| Q2 2015 | $168,000 | – | 20,845 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ulys, L.L.C. | 4,321,214 | $71,084,000 | 100.00% |
| Artal Group S.A. | 57,517,977 | $946,170,000 | 16.53% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 35,714 | $587,000 | 1.74% |
| SECTOR GAMMA AS | 622,655 | $10,243,000 | 1.49% |
| NEA Management Company, LLC | 2,382,286 | $39,189,000 | 1.43% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 606,410 | $9,975,000 | 0.68% |
| MOODY ALDRICH PARTNERS LLC | 30,930 | $509,000 | 0.64% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 499,200 | $8,212,000 | 0.56% |
| USS Investment Management Ltd | 3,507,900 | $57,705,000 | 0.54% |
| Rock Springs Capital Management LP | 393,500 | $6,473,000 | 0.33% |